51
Participants
Start Date
August 31, 2011
Primary Completion Date
October 14, 2017
Study Completion Date
October 14, 2017
Escitalopram
An open-label, 10-20 mg/day, flexible-dose of escitalopram will be administered to all subjects included in this study in the form of tablets. The treatment period is 8 weeks long.
Healthy Control
No Treatment
Depression Clinical and Research Program, MGH, Boston
Massachusetts General Hospital
OTHER
Martinos Center for Biomedical Imaging
OTHER
Massachusetts Institute of Technology
OTHER
Wyss Institute at Harvard University
OTHER